Primed for a biotech boom

Article Abstract:

The biotechnology industry in Osaka is making effort to rival the successful US biotech industry as the Japan's drug industry has sales of some US $60 billion and the pharmaceutical companies grouped in greater Osaka account for 13% of this total. Some of the efforts include building the 743-hectare Saito Science Park, Osaka Chamber of Commerce and Industry, and Osaka's bid to become Japan's biomedical center.

Japan, Market share, Company market share, Osaka, Japan

---

Capital collaboration Washington DC

Article Abstract:

In Washington DC, institutions like University of Maryland and Hopkins hope to expand industry collaborations as biotech in the area continues to grow. With the new interdisciplinary centres and a rise in the number of biotech companies, the Washington DC area should see an overall growth in the number of scientific jobs this year.

Washington, DC, Washington, D.C.

---

Bound for Boston

Article Abstract:

Boston is the hub for biotechnology companies, with its top academic institutions, but the demand for more academic input into industrial science is attracting top drug companies there too. The drug companies hope that being close to so many potential academic and biotech collaborators will help them reinvigorate drug development.

Massachusetts, Boston, Massachusetts

Similar abstracts:

• Abstracts: Hwang scandal hit Korean biotech hard. Too much, too soon. An auspicious victory
• Abstracts: Doubling the estimate of invertebrate biomass in a rainforest canopy. FKF1 is essential for photoperiodic-specific light signalling in Arabidopsis
• Abstracts: Performance variability enables adaptive plasticity of 'crystallized' adult birdsong. Interruption of a basal ganglia-forebrain circuit prevents plasticity of learned vocalizations

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.